Istanbul Medeniyet University, Goztepe Research and Training Hospital
Istanbul, Kadikoy, 34722, Turkey (Türkiye)
NCT Number: NCT04100252
Pregnant women who admitted with the complaint of amniotic fluid leakage between the gestational ages of 23+0 and 33+0 and who finally were diagnosed as PPROM were included in the study. Women with multiple gestations, cervical dilatation above 6 cm at the admission, hypertensive diseases, cervical cerclage, fetal anomalies, olgohydramnios, polihydramnios, and those who declined to involve in the study were excluded.
In all included women were examined at the admission for amniotic fluid index via trans abdominal ultrasonography. AFI were measured by four quadrant technique, which is sum of the deepest vertical length of pocket of fluid in each quadrant without any umbilical cord. All included patients were assessed in two groups; women with AFI<5 and those with AFI≥5 cm.
Included patients were followed in terms of maternal and fetal complications. Maternal complications were chorioamnionitis, placental abruption, placental retention, postpartum endometritis, postpartum hemorrhage; while fetal complications comprised necessity of admission to neonatal intensive care unit, neonatal sepsis, meconium aspiration syndrome, respiratory distress syndrome, intraventricular hemorrhage, umbilical cord pH below 7.10, APGAR score of 5th minute below 5. All complication rates were compared between the groups. In addition, the time period between the diagnosis of PPROM and the time of delivery was defined as latency period and were compared between the groups.
Looking for future studies?
Notify Me18 year–40 year
Female
Observational
Istanbul, Kadikoy, 34722, Turkey (Türkiye)
Pregnant women who admitted with the complaint of amniotic fluid leakage between the gestational ages of 23+0 and 33+0 were examined for the inclusion criteria of the study. Among them, women with usual history of gross amniotic fluid leakage as well as classical speculum findings of ROM, such as pooling of amnitotic fluid within the posterior fornix or vaginal wall, were diagnosed as PPROM and included in the study without any further investigation. In case of the absence of these findings and suspected cases, PPROM was diagnosed via placental alpha-microglobulin-1 test from the vaginal fluid. Those with positive test results were included in the study. Women with multiple gestations, cervical dilatation above 6 cm at the admission, hypertensive diseases, cervical cerclage, fetal anomalies, olgohydramnios, polihydramnios, and those who declined to involve in the study were excluded.
In all included women were examined at the admission for amniotic fluid index via trans abdominal ultrasonography. AFI were measured by four quadrant technique, which is sum of the deepest vertical length of pocket of fluid in each quadrant without any umbilical cord. All included patients were assessed in two groups; women with AFI<5 and those with AFI≥5 cm.
Included patients were followed in terms of maternal and fetal complications. Maternal complications were chorioamnionitis, placental abruption, placental retention, postpartum endometritis, postpartum hemorrhage; while fetal complications comprised necessity of admission to neonatal intensive care unit, neonatal sepsis, meconium aspiration syndrome, respiratory distress syndrome, intraventricular hemorrhage, umbilical cord pH below 7.10, APGAR score of 5th minute below 5. All complication rates were compared between the groups. In addition, the time period between the diagnosis of PPROM and the time of delivery was defined as latency period and were compared between the groups.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Pregnant women Diagnosis of PPROM between 23+0 and 33+0 gestational ages. -
Exclusion criteria
Multiple gestations, C Cervical dilatation above 6 cm at the admission, Hypertensive diseases, Cervical cerclage, Fetal anomalies, Oligohydramnios, Polihydramnios, Those who declined to participate in the study.
-
AFI via transabdominal ultrasonography was performed at the time of diagnosis.
Time frame: Through study completion, an average of 1 year
Adverse events emerging in included pregnant women from the time of PPROM diagnosis to the end of the postpartum 1st month
Time frame: Through study completion, an average of 1 year
Adverse events emerging in fetuses and neonates from the time of PPROM diagnosis to the end of the postpartum 1st month
Time frame: Through study completion, an average of 1 year
The time period from the PPROM diagnosis to delivery.
Istanbul Medeniyet University
Other
The Impact of Amniotic Fluid Index (AFI) on Maternal and Perinatal Outcomes in Pregnant Women With Preterm Premature Rupture of Membranes (PPROM)
Acronym: AFI in PPROM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04478942
Female Urogenital Diseases and Pregnancy Complications, Fetal Membranes, Premature Rupture
Madison, Wisconsin, United States
View Trial DetailsNCT03251898
Female Urogenital Diseases and Pregnancy Complications, Fetal Membranes, Premature Rupture
Chengdu, China
View Trial DetailsNCT03491826
Female Urogenital Diseases and Pregnancy Complications, Fetal Membranes, Premature Rupture
Cairo, Egypt
View Trial DetailsNCT03106311
Female Urogenital Diseases and Pregnancy Complications, Fetal Membranes, Premature Rupture
Cairo, Greater Cairo, Egypt
View Trial Details